Josje Langenveld

Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial

Brenda M. Kazemier, Fiona N. Koningstein, Caroline Schneeberger et al. · The Lancet Infectious Diseases · 2015 · 208 citations

Medicine, Maternal Health, Obstetrics +15

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial

Kim Broekhuijsen, Gert‐Jan van Baaren, Maria G. van Pampus et al. · The Lancet · 2015 · 204 citations

Public Health, Maternal Health, Obstetrics +13

Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial

Daphne N. Voormolen, J. Hans DeVries, Rieneke M. E. Sanson et al. · Diabetes Obesity and Metabolism · 2018 · 151 citations · Full text

Public Health, Maternal Health, Obstetrics +17

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

Ingrid M. Bistervels, Andréa Buchmuller, Hanke M.G. Wiegers et al. · The Lancet · 2022 · 111 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +16

Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37 weeks of gestation: a 7 year retrospective analysis of a national registry

Josje Langenveld, Anita C.J. Ravelli, Anton H. van Kaam et al. · American Journal of Obstetrics and Gynecology · 2011 · 76 citations · Full text

Public Health, Maternal Health, Obstetrics +12